Does biopsy type influence survival in clinical Stage I cutaneous melanoma?
β Scribed by Lederman, Josiane S.; Sober, Arthur J.
- Book ID
- 121770458
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 657 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1097-6787
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Inclusion of patients referred to our cancer center following recurrence, by retracing the history and characteristics of these patients back to when they were in stage I, produced a bias that lowered the estimated diseasefree survival rates. However, taking into consideration only patients referred
The authors have studied the natural history of 377 patients with Stage I cutaneous malignant melanoma followed at the Arizona Cancer Center, Tucson. Two hundred eight patients, or 55%, remained free of metastatic disease after a median follow-up of 30 months. The survival at 5,8, and 10 years was 6
## Abstract ## Background Sentinel lymph node biopsy (SNB) is a widely adopted staging procedure in patients with cutaneous melanoma. The benefits of SNB have not been evaluated thoroughly in older age groups. ## Methods This was a two-centre retrospective observational study of patients with me